José María
Pego Reigosa
Hospital de la Santa Creu i Sant Pau
Barcelona, EspañaPublicacións en colaboración con investigadores/as de Hospital de la Santa Creu i Sant Pau (10)
2023
-
Immunoglobulins in systemic sclerosis management. A large multicenter experience
Autoimmunity Reviews, Vol. 22, Núm. 11
2022
-
Myo-Spain: Spanish Registry of Patients with Idiopathic Inflammatory Myopathy. Methodology
Reumatologia Clinica, Vol. 18, Núm. 5, pp. 253-259
2021
-
Do all antiphospholipid antibodies confer the same risk for major organ involvement in systemic lupus erythematosus patients?
Clinical and Experimental Rheumatology, Vol. 39, Núm. 3, pp. 555-563
2020
-
Antiphospholipid syndrome (APS) in patients with systemic lupus erythematosus (SLE) implies a more severe disease with more damage accrual and higher mortality
Lupus, Vol. 29, Núm. 12, pp. 1556-1565
-
Clinical features and outcomes of COVID-19 in patients with rheumatic diseases treated with biological and synthetic targeted therapies
Annals of the Rheumatic Diseases
-
Prevalence and factors associated with osteoporosis and fragility fractures in patients with primary Sjögren syndrome
Rheumatology International, Vol. 40, Núm. 8, pp. 1259-1265
2017
-
Incidence, associated factors and clinical impact of severe infections in a large, multicentric cohort of patients with systemic lupus erythematosus
Seminars in Arthritis and Rheumatism, Vol. 47, Núm. 1, pp. 38-45
2016
-
Characterization of patients with lupus nephritis included in a large cohort from the Spanish society of rheumatology registry of patients with systemic lupus erythematosus (RELESSER)
Medicine (United States), Vol. 95, Núm. 9
-
Relationship between damage clustering and mortality in systemic lupus erythematosus in early and late stages of the disease: Cluster analyses in a large cohort from the Spanish Society of Rheumatology Lupus Registry
Rheumatology (United Kingdom), Vol. 55, Núm. 7, pp. 1243-1250
-
Urine metabolome profiling of immune-mediated inflammatory diseases
BMC Medicine, Vol. 14, Núm. 1